PURPOSES: We tested the hypotheses that women have greater impairment in calf muscle hemoglobin oxygen saturation (StO(2)) in response to exercise than men, and that the sex-related difference in calf muscle StO(2) would partially explain the shorter claudication distances of women. METHODS: The study comprised 27 men and 24 women with peripheral arterial disease limited by intermittent claudication. Patients were characterized on calf muscle StO(2) before, during, and after a graded treadmill test, as well as on demographic and cardiovascular risk factors, ankle-brachial index (ABI), ischemic window, initial claudication distance (ICD), and absolute claudication distance (ACD). RESULTS: Women had a 45% lower ACD than men (296 +/- 268 m vs 539 +/- 288 m; P = .001) during the treadmill test. Calf muscle StO(2) declined more rapidly during exercise in women than in men; the time to reach minimum StO(2) occurred 54% sooner in women (226 +/- 241 vs 491 +/- 426 seconds; P = .010). The recovery time for calf muscle StO(2) to reach the resting value after treadmill exercise was prolonged in women (383 +/- 365 vs 201 +/- 206 seconds; P = .036). Predictors of ACD included the time from start of exercise to minimum calf muscle StO(2), the average rate of decline in StO(2) from rest to minimum StO(2) value, the recovery half-time of StO(2), and ABI (R(2) = 0.70; P < .001). The ACD of women remained lower after adjusting for ABI (mean difference, 209 m; P = .003), but was no longer significantly lower (mean difference, 72 m; P = .132) after further adjustment for the StO(2) variables for the three calf muscles. CONCLUSION: In patients limited by intermittent claudication, women have lower ACD and greater impairment in calf muscle StO(2) during and after exercise than men, the exercise-mediated changes in calf muscle StO(2) are predictive of ACD, and women have similar ACD as men after adjusting for calf StO(2) and ABI measures.
PURPOSES: We tested the hypotheses that women have greater impairment in calf muscle hemoglobinoxygen saturation (StO(2)) in response to exercise than men, and that the sex-related difference in calf muscle StO(2) would partially explain the shorter claudication distances of women. METHODS: The study comprised 27 men and 24 women with peripheral arterial disease limited by intermittent claudication. Patients were characterized on calf muscle StO(2) before, during, and after a graded treadmill test, as well as on demographic and cardiovascular risk factors, ankle-brachial index (ABI), ischemic window, initial claudication distance (ICD), and absolute claudication distance (ACD). RESULTS:Women had a 45% lower ACD than men (296 +/- 268 m vs 539 +/- 288 m; P = .001) during the treadmill test. Calf muscle StO(2) declined more rapidly during exercise in women than in men; the time to reach minimum StO(2) occurred 54% sooner in women (226 +/- 241 vs 491 +/- 426 seconds; P = .010). The recovery time for calf muscle StO(2) to reach the resting value after treadmill exercise was prolonged in women (383 +/- 365 vs 201 +/- 206 seconds; P = .036). Predictors of ACD included the time from start of exercise to minimum calf muscle StO(2), the average rate of decline in StO(2) from rest to minimum StO(2) value, the recovery half-time of StO(2), and ABI (R(2) = 0.70; P < .001). The ACD of women remained lower after adjusting for ABI (mean difference, 209 m; P = .003), but was no longer significantly lower (mean difference, 72 m; P = .132) after further adjustment for the StO(2) variables for the three calf muscles. CONCLUSION: In patients limited by intermittent claudication, women have lower ACD and greater impairment in calf muscle StO(2) during and after exercise than men, the exercise-mediated changes in calf muscle StO(2) are predictive of ACD, and women have similar ACD as men after adjusting for calf StO(2) and ABI measures.
Authors: J I Weitz; J Byrne; G P Clagett; M E Farkouh; J M Porter; D L Sackett; D E Strandness; L M Taylor Journal: Circulation Date: 1996-12-01 Impact factor: 29.690
Authors: Andrew W Gardner; Donald E Parker; Nykita Webb; Polly S Montgomery; Kristy J Scott; Steve M Blevins Journal: J Vasc Surg Date: 2008-06-24 Impact factor: 4.268
Authors: Azhar Afaq; Polly S Montgomery; Kristy J Scott; Steve M Blevins; Thomas L Whitsett; Andrew W Gardner Journal: Vasc Med Date: 2007-08 Impact factor: 3.239
Authors: Andrew W Gardner; Donald E Parker; Polly S Montgomery; Aman Khurana; Raphael M Ritti-Dias; Steve M Blevins Journal: J Vasc Surg Date: 2012-02-16 Impact factor: 4.268
Authors: Aman Khurana; Julie A Stoner; Thomas L Whitsett; Suman Rathbun; Polly S Montgomery; Andrew W Gardner Journal: Angiology Date: 2012-05-17 Impact factor: 3.619
Authors: J Carter Luck; Amanda J Miller; Faisal Aziz; John F Radtka; David N Proctor; Urs A Leuenberger; Lawrence I Sinoway; Matthew D Muller Journal: J Appl Physiol (1985) Date: 2017-04-06
Authors: Andrew W Gardner; Donald E Parker; Polly S Montgomery; Aman Khurana; Raphael M Ritti-Dias; Steve M Blevins Journal: J Vasc Surg Date: 2010-08-08 Impact factor: 4.268
Authors: Andrew W Gardner; Donald E Parker; Polly S Montgomery; Danuta Sosnowska; Ana I Casanegra; Zoltan Ungvari; Anna Csiszar; William E Sonntag Journal: J Vasc Surg Date: 2014-04-03 Impact factor: 4.268